Hyperkinetic Movement Disorder Caused by the Recurrent c. 892C >T NACC1 Variant is a research paper published in Movement Disorders Clinical Practice (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Pohjois-Pohjanmaan Rahasto
Grant: 60152194
Medical Research Council
Grant: MR/S020136/1
Rosetrees Trust
Grant: CF2/100018
Sir Jules Thorn Charitable Trust
Grant: JTA‐017
National Institute for Health and Care Research
Grant: NIHR‐RP_2016‐07‐019
Clinical Center
Grant: 5U54‐NS078059
Clinical Center
Grant: 5U54‐NS115198 03
Instituto de Salud Carlos III
Grant: PTC20CIII/00009
Research Council of Finland
Grant: 331 436
U.S. Food and Drug Administration
Grant: 5R01‐FD005407
FDA HHS
Grant: R01 FD005407
Sir Jules Thorn Charitable Trust
Grant: JTA-017
FDA HHS
Grant: 5R01-FD005407
CLC NIH HHS
Grant: 5U54-NS115198 03
NINDS NIH HHS
Grant: U54 NS115198
National Institute for Health and Care Research
Grant: NIHR-RP_2016-07-019
NINDS NIH HHS
Grant: U54 NS078059
University of Oulu and Academy of Finland profiling program
Grant: #311934
CLC NIH HHS
Grant: 5U54-NS078059
Arvo ja Lea Ylppö Säätiö, Helsinki, Finland
Oulun Yliopistollinen Sairaala
Lastentautien Tutkimussäätiö
Astellas Pharmaceuticals
PTC Therapeutics
Stiftelsen Alma och K. A. Snellman Säätiö
FWCI
0.66
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals